Peripheral Vascular Disease (PVD) Diagnostics Market: By Diagnosis Type (Ankle-brachial index (ABI), Doppler Ultrasound, Angiography, Others),  By End User (Hospitals & Diagnostic Labs, Ambulatory Surgical Centers, Others), and by Geography

Purchase Option

$ 4400
$ 6600
$ 8900

1. Executive Summary
2. Global Peripheral Vascular Disease (PVD) Diagnostics Market Introduction
2.1. Global Peripheral Vascular Disease (PVD) Diagnostics Market – Taxonomy
2.2. Global Peripheral Vascular Disease (PVD) Diagnostics Market –Definitions
2.2.1. By Diagnosis Type
2.2.2. By End User
2.2.3. By Region
3. Global Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Peripheral Vascular Disease (PVD) Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Peripheral Vascular Disease (PVD) Diagnostics Market – Competition Landscape
4. Global Peripheral Vascular Disease (PVD) Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Peripheral Vascular Disease (PVD) Diagnostics Market, By Diagnosis Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Ankle-brachial index (ABI)
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Doppler Ultrasound
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Angiography
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Peripheral Vascular Disease (PVD) Diagnostics Market Forecast, By End User, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Hospitals & Diagnostic Labs
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Ambulatory Surgical Centers
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Peripheral Vascular Disease (PVD) Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Region, 2022-2028
8. North America Peripheral Vascular Disease (PVD) Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Ankle-brachial index (ABI)
8.1.2. Doppler Ultrasound
8.1.3. Angiography
8.1.4. Others
8.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospitals & Diagnostic Labs
8.2.2. Ambulatory Surgical Centers
8.2.3. Others
8.3. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028
8.5. North America Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends
9. Europe Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Ankle-brachial index (ABI)
9.1.2. Doppler Ultrasound
9.1.3. Angiography
9.1.4. Others
9.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospitals & Diagnostic Labs
9.2.2. Ambulatory Surgical Centers
9.2.3. Others
9.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028
9.5. Europe Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends
10. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Ankle-brachial index (ABI)
10.1.2. Doppler Ultrasound
10.1.3. Angiography
10.1.4. Others
10.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospitals & Diagnostic Labs
10.2.2. Ambulatory Surgical Centers
10.2.3. Others
10.3. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028
10.5. Asia-Pacific Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends
11. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Ankle-brachial index (ABI)
11.1.2. Doppler Ultrasound
11.1.3. Angiography
11.1.4. Others
11.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospitals & Diagnostic Labs
11.2.2. Ambulatory Surgical Centers
11.2.3. Others
11.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028
11.5. Latin America Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends
12. Middle East and Africa Peripheral Vascular Disease (PVD) Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Diagnosis Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Ankle-brachial index (ABI)
12.1.2. Doppler Ultrasound
12.1.3. Angiography
12.1.4. Others
12.2. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospitals & Diagnostic Labs
12.2.2. Ambulatory Surgical Centers
12.2.3. Others
12.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Peripheral Vascular Disease (PVD) Diagnostics Market - Opportunity Analysis Index, By Diagnosis Type, End User, and Country, 2022-2028
12.5. MEA Peripheral Vascular Disease (PVD) Diagnostics Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Diagnostics & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Arjo AB
13.2.2. D. E. Hokanson Inc
13.2.3. Fukuda Denshi Co. Ltd
13.2.4. Koven Technology Inc
13.2.5. Perimed AB
13.2.6. Unetixs Vascular Inc
13.2.7. Viasonix Ltd.
13.2.8. BiomediX
14. Research Methodology
15. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • Arjo AB
  • E. Hokanson Inc
  • Fukuda Denshi Co. Ltd
  • Koven Technology Inc
  • Perimed AB
  • Unetixs Vascular Inc
  • Viasonix Ltd.
  • BiomediX

Adjacent Markets